Operation. The patient was medically stabilized and taken to the operating room for resection of the tumor. At operation, a left atrial wall mass measuring 3.2 × 2.3 × 1.8 cm was resected. The mitral valve was exten sively involved with tumor, precluding the placement of an artificial valve. Invasion of the right upper and lower pulmonary veins similarly limited the amount of tumor that could be removed. Histopathological analysis of the tissue confirmed the tumor as a high-grade cardiac sar coma. Chemotherapy was implemented, consisting of 4 cycles of ifosfamide, carboplatin, and etoposide. Unfortu nately, local recurrence occurred within a month of sur gery, and given her young age, consideration was given to a heart-lung transplant.
Because metastasis contraindicates transplantation at our institutions, the patient underwent an extensive screening process. A lumbar spine MR imaging study was significant for heterogeneous marrow signal changes of the L3 and L5 VBs. These regions also showed en hancement after administration of Gd contrast (Fig. 1) . These findings implicated possible metastatic disease or incidental vertebral hemangiomas. The bone scan was negative. A PET scan demonstrated some increased up take, but only within the L3 VB.
The patient underwent a total of 3 separate spinal bi opsy procedures. Initially, a radiologist performed a CT guided biopsy of the L3 VB. The specimen was thought to be inadequate on pathological examination, and there fore a spine surgeon performed an open biopsy of L3. A subsequent transpedicular trocar biopsy of L5 was also performed by another surgeon. All histopathological re sults were negative for malignancy. Although the MR im aging signal changes at the L3 and L5 levels persisted, the patient remained asymptomatic and the neuroimag ing findings did not change for 1 year after the biopsies. Followup bone scans also remained negative. Therefore, a heart-lung transplant proceeded, with the patient mak ing a good recovery. The postoperative immune suppres sion regimen consisted of tacrolimus initially and then sirolimus.
Histopathological Analysis. The explanted cardiac tu mor measured 6 × 3.5 × 1.1 cm. The lungs and hilar lymph nodes did not harbor evidence of malignancy. Mi croscopically, the tumor was cellular and exhibited nu clear pleomorphism, hyperchromasia, and frequent mitot ic figures. Spindle-shaped cells predominated, with ov al, multinucleated cells interspersed (Fig. 2) . Immunocy to chemical evaluation demonstrated strong immunopo sitivity for vimentin and immunonegativity for myosin, desmin, and smoothactin myosin. The histopathological diagnosis was again consistent with an undifferentiated pleomorphic cardiac sarcoma.
Postoperative Course. Several months after trans plantation, the patient began experiencing lowback pain. This was associated with occasional episodes of transient weakness of the lower extremities. An MR imaging study revealed that the signal change at L5 had been replaced by an extradural tumor involving the VB and right pedi cle. Interestingly, the signal change at L3 remained un changed. The PET images now demonstrated prominent uptake within the L5 VB. Additional investigations re vealed sacral and hepatic lesions, and analysis of biopsy samples proved these to be metastatic cardiac sarcoma.
Second Operation and Outcome. The patient was referred for palliative radiation therapy. In the interim, however, she developed an acute onset of bilateral foot drop, loss of the left ankle reflex, and diminished sensa tion throughout the L5-S1 distribution. Bowel and blad der function were preserved. An emergency MR image demonstrated complete replacement of the VB and right pedicle with tumor, loss of VB height, and anterior epi dural compression resulting in complete canal block (Fig.  3) . Cauda equina syndrome secondary to epidural tumor compression was diagnosed. The patient was taken to the operating room for emergency L4-5 laminectomy and epidural decompression, L4-S1 posterolateral instru mented fusion with pedicle screws, and L5 bipedicular vertebroplasty. The histopathological analysis of the re sected L5 tumor was consistent with the primary cardiac tumor.
Following surgery the patient's neurological status im proved. She retained her ability to walk, and continued to progress with physiotherapy. Unfortunately, several weeks after surgery and despite an initially encouraging re covery, the patient died.
Discussion
Primary cardiac tumors are rare, occurring with an estimated incidence of 0.0017-0.0028%. 20, 21, 28 Although benign myxomas comprise the majority of these neo plasms, 25% are malignant, with a clear predilection to ward sarcoma. 4 Undifferentiated sarcomas, which com prise the majority of the sarcoma variants, are unique in that they lack a clear tissue lineage and do not demon strate a histological and immunohistochemical profile. Independent of histological type, however, cardiac sarco mas have a uniformly poor prognosis, with mean survival times ranging between 9 and 16.5 months. 6, 8, 20 Wide excision combined with chemotherapy is the pre ferred treatment for cardiac sarcomas. 6 Marginfree resec tions have been demonstrated to improve survival by up to 50%. 19, 20 Recently, cardiac autotransplantation has been used successfully to facilitate resection. [22] [23] [24] In this case, the patient underwent a heart-lung transplant be cause the tumor involved the pulmonary veins. Less clear, however, is the role for orthotopic transplantation for unresectable tumors. 10 In theory, this approach provides an opportunity for radical resection, which would translate into a lower incidence of systemic recurrence. 31 However, this is often not the case. Metastases in the setting of immunosuppres sion have been reported, in some cases when systemic disease had been excluded prior to the transplant. 7, 17, 29 To our knowledge, this represents the first case of an undifferentiated cardiac sarcoma metastasizing to the spi nal column and producing cauda equina syndrome. This occurred following an exhaustive search for metastatic disease prior to the transplantation, including 3 separate biopsy procedures and ongoing use of the most advanced imaging technologies available. In this case, the possibil ity remains that immunosuppression led to the prolifera tion of an otherwise clinically and radiographically silent disease.
The fact that no single diagnostic test has 100% sen sitivity and specificity for detecting spinal column me tastases is important, because most authors believe that progression to transplantation should be done only when systemic disease has been excluded. Magnetic resonance imaging, in particular short tau inversion recovery imag es, is reported to be the most sensitive modality for spinal column metastases. For this purpose, MR imaging has a sensitivity and specificity of 93% and 97%, respectively. 30 Bone scintigraphy is less sensitive than MR imaging, es pecially if there is a lack of cortical bone involvement. 30 The modality [
18 F]fluorodeoxyglucose-PET has recently been used for metastatic spine disease, with reports of sensitivity of up to 98%. 16 With respect to biopsy proce dures, a CTguided needle biopsy has a diagnostic accu racy of 71-89%, whereas a transpedicular trocar biopsy has an accuracy rate of 92%. 2, 12, 14 Despite the fact that this pa tient underwent all of these procedures on numerous occasions, in this case a definitive diagnosis of metastatic disease eluded investigators.
Systemic disease in patients with cardiac sarcoma is not uncommon. Although metastases are more frequent with sarcoma variants localized to the left side of the heart, all types are capable of metastasizing, and they represent an important factor in the patient mortality rate. 4, 9, 13, 18 Metastatic disease of the spinal column is distinctly un common, however, especially for an undifferentiated sar coma. 1, 5 A high degree of clinical suspicion is required to diagnosis this condition because patients may report only nonspecific back pain; subtle neurological deficits may be present on examination or occur in a delayed fashion as the tumor gradually compresses the spinal cord or nerve roots. 3, 26, 27, 32 It is important to differentiate between spinal cord involvement and cerebral lesions, because intracra nial metastases are fairly common with cardiac sarco mas. 25 The multidisciplinary team involved in caring for these patients should recognize that metastases may oc cur after transplantation despite negative results on pre transplantation screening studies. Reports of back pain should prompt a thorough clinical and radiographic as sessment to rule out spinal column metastases. Although cerebral metastases are well documented in patients with cardiac sarcoma, it should be recognized that neurologi cal deficits may be precipitated by spinal cord compres sion. This may allow for timely intervention to minimize neu rological morbidity.
Conclusions
The role of orthotopic transplantation for cardiac sarcoma has yet to be defined. Although this procedure allows for radical resection, it remains unclear how post transplantation immunosuppressive therapy relates to the development of systemic disease. This case provides an example of rare spinal metastases following transplanta tion in a patient receiving immunosuppressant therapy.
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